Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Qualigen Therapeutics, Inc. (QLGN)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.5645-0.0175 (-3.01%)
At close: 04:00PM EDT
0.5650 +0.00 (+0.09%)
After hours: 07:57PM EDT
Advertisement
Full screen
Loading interactive chart...
  • GlobeNewswire

    Qualigen Therapeutics to Present at BIO International Convention

    Qualigen Therapeutics, Inc. Tariq Arshad CARLSBAD, Calif., June 14, 2022 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a diversified life sciences company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug Designation, while also commercializing diagnostics, today announces that Qualigen Therapeutics will present a corporate overview at the BIO International Convention to be held on June 13 – 16, 2022 at the San Diego Convention Cent

  • GlobeNewswire

    Qualigen Therapeutics Announces IND-Enabling Studies to Advance Lead Program QN-302 Toward Clinical Trials

    A Potential Treatment for Pancreatic Cancer in Addition to Other Tumors of High Unmet Clinical Need CARLSBAD, Calif., June 07, 2022 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a diversified life sciences company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug Designation, while also commercializing diagnostics, today announces it has initiated Investigational New Drug, or IND-enabling, studies for its lead therapeutic program, Q

  • Zacks Small Cap Research

    QLGN: Acquires Majority Stake in Israeli Diagnostics Technology Company NanoSynex…

    By David Bautz, PhD NASDAQ:QLGN READ THE FULL QLGN RESEARCH REPORT Business Update Acquires Majority Stake in NanoSynex On May 3, 2022, Qualigen Therapeutics, Inc. (NASDAQ:QLGN) entered into a definitive agreement to acquire a majority stake in NanoSynex Ltd., an Israeli-based diagnostics company developing the Antimicrobial Susceptibility Testing (AST) platform. The goal of AST is to provide

Advertisement
Advertisement